Quick Takeaways
- MFN Partners Management, LP filed SCHEDULE 13G/A for Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2024.
MFN Partners Management, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN)
- Filing Manager
- MFN Partners Management, LP
- Reporting Manager
- MFN Partners, LP
- Symbol
- CYCN
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 15:36:42 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"MFN Partners Management, LP disclosed 0% ownership in Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 15:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (6)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| MFN Partners, LP | 0% | 0 | 0 | 0 | /s/ Jonathan Reisman | Jonathan Reisman, Authorized Person | |
| MFN Partners GP, LLC | 0% | 0 | 0 | 0 | /s/ Jonathan Reisman | Jonathan Reisman, Authorized Person | |
| MFN Partners Management, LP | 0% | 0 | 0 | 0 | /s/ Jonathan Reisman | Jonathan Reisman, Authorized Person | |
| MFN Partners Management, LLC | 0% | 0 | 0 | 0 | /s/ Jonathan Reisman | Jonathan Reisman, Authorized Person | |
| Michael F. DeMichele | 0% | 0 | 0 | 0 | /s/ Michael F. DeMichele | Michael F. DeMichele, individually | |
| Farhad Nanji | 0% | 0 | 0 | 0 | /s/ Farhad Nanji | Farhad Nanji, individually |